Abstract:Objectives Hyperglycemia during acute myocardial infarction is common and associated with increased mortality. Thioredoxin-interacting protein (Txnip) is a modulator of cellular redox stateand contributes to cell apoptosis. The present study was aimed to investigate whether hyperglycemia enhances Txnip expression in myocardialischaemia/reperfusion (MI/R) and consequently exacerbates MI/R injury. Methods Adult male Sprague-Dawley rats were subjected to MI/R (anaesthetised with 60 mg/kg pentobarbital sodium, intraperitoneally, MI 30 min / R 4 h) and treated with saline or high glucose (HG, 500 g/L, 4 ml/kg/h, intravenously). In vitro study was performed on cultured neonatal rat cardiomyocytes subjected to simulated ischaemia/reperfusion (SI/R) and incubated with HG (25 mM) or normal glucose (5.6 mM) medium. Results In vivo HG infusion during MI/R significantly reduced the instantaneous first derivation of left ventricle pressure (± LVdP/dtmax) by 13.2 and 14.1% respectively (n = 8, P < 0.05), increased infarct size and myocardial apoptosis (P < 0.05) and increased superoxide accumulation (P < 0.01) compared with those in the saline group. Meanwhile, Txnip expression was enhanced (Ratio of Txnip/β-actin: 1.22 ± 0.16 vs. 0.92 ± 0.05 of MI/R + saline, n = 6-8, P < 0.05) whereas thioredoxin activity was inhibited (0.50 ± 0.05 vs. 1.41 ± 0.06 μmol/min/mg protein, P < 0.01) following HG treatment in ischaemia/reperfusion (I/R) hearts. Additionally, HG significantly activated p38 mitogen-activated protein kinase (p38 MAPK) and inhibited Akt in I/R hearts (both P < 0.05). In cultured cardiomyocytes subjected to SI/R, HG incubation stimulated Txnip expression and reduced thioredoxin activity (n = 6, P < 0.05). Overexpression of Txnip enhancedHG-induced superoxide generation and aggravated cardiomyocyte apoptosis (n = 6, P < 0.05), while Txnip siRNA significantly blunted the deleterious effects of HG (P < 0.05). Moreover, inhibition of p38 MAPK or activation of Akt markedly blocked HG-induced Txnip expression in I/R cardiomyocytes. Most importantly, intramyocardial injection of Txnip siRNA markedly decreased Txnip expression and alleviated MI/R injury as evidenced by reduced infarction size (23.7 ± 1.6% vs. 43.1 ± 4.8%, n = 6, P < 0.05) and caspase 3 activity (3.05 ± 0.08 vs. 3.93 ± 0.31 nmol/h/mg protein, P < 0.05) in HG-treated rats. Conclusions Hyperglycemia enhances myocardial Txnip expression, possibly through reciprocally modulating p38 MAPK and Akt activation, leading to aggravated oxidative stress and subsequent amplification of cardiac injury following MI/R.

TXNIP Mediated the Oxidative Stress Response in Glomerular Mesangial Cells Partially Through AMPK Pathway.

Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells

TXNIP-mediated crosstalk between oxidative stress and glucose metabolism

TXNIP deficiency attenuates renal fibrosis by modulating mTORC1/TFEB-mediated autophagy in diabetic kidney disease

TXNIP Links Innate Host Defense Mechanisms to Oxidative Stress and Inflammation in Retinal Muller Glia under Chronic Hyperglycemia: Implications for Diabetic Retinopathy

TXNIP regulates mitophagy in retinal Müller cells under high-glucose conditions: implications for diabetic retinopathy

TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy

p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells.

Thioredoxin-Interacting Protein Deficiency Alleviates Phenotypic Alterations Of Podocytes Via Inhibition Of Mtor Activation In Diabetic Nephropathy

Up-regulation of Thioredoxin Interacting Protein (txnip) by P38 MAPK and FOXO1 Contributes to the Impaired Thioredoxin Activity and Increased ROS in Glucose-Treated Endothelial Cells.

FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX

TXNIP positively regulates the autophagy and apoptosis in the rat müller cell of diabetic retinopathy

Role of Thioredoxin-Interacting Protein in Diabetic Fatty Kidney Induced by Advanced Glycation End-Products

Thioredoxin-interacting Protein Mediates NALP3 Inflammasome Activation in Podocytes During Diabetic Nephropathy.

Thioredoxin-Interacting Protein Mediates NLRP3 Inflammasome Activation Involved in the Susceptibility to Ischemic Acute Kidney Injury in Diabetes

TXNIP knockdown ameliorates hepatic ischemia/reperfusion injury by inhibiting apoptosis and improving mitochondrial dysfunction via HIF-1α

Thioredoxin1 Inactivation Mediates the Impairment of Ischemia-Induced Angiogenesis and Further Injury in Diabetic Myocardium

TXNIP Exacerbates the Senescence and Aging-Related Dysfunction of β Cells by Inducing Cell Cycle Arrest Through p38-p16/p21-CDK-Rb Pathway

CKIP-1 Ameliorates High Glucose-Induced Expression of Fibronectin and Intercellular Cell Adhesion Molecule-1 by Activating the Nrf2/ARE Pathway in Glomerular Mesangial Cells

Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis

GW24-e1280 Thioredoxin-interacting Protein Contributes to Aggravated Myocardial Ischaemia/reperfusion Injury by Hyperglycemia